出典: meddic

Prezista, DRV

Wikipedia preview

出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2015/08/31 16:48:12」(JST)

wiki en

[Wiki en表示]

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.


  • Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate in the First Protease Inhibitor-Based Single-Tablet Regimen for Initial HIV-1 Therapy: A Randomized Phase 2 Study.
  • Mills A1, Crofoot G Jr, McDonald C, Shalit P, Flamm JA, Gathe J Jr, Scribner A, Shamblaw D, Saag M, Cao H, Martin H, Das M, Thomas A, Liu HC, Yan M, Callebaut C, Custodio J, Cheng A, McCallister S.
  • Journal of acquired immune deficiency syndromes (1999).J Acquir Immune Defic Syndr.2015 Aug 1;69(4):439-45. doi: 10.1097/QAI.0000000000000618.
  • OBJECTIVES: To evaluate the safety and efficacy of the novel tenofovir prodrug, tenofovir alafenamide (TAF), as part of the first protease inhibitor-based single-tablet regimen (STR) for initial treatment of HIV-1 infection.METHODS: Antiretroviral therapy (ART)-naive adults with estimated glomerular
  • PMID 25867913
  • Solid self-nanoemulsifying drug delivery system (S-SNEDDS) of darunavir for improved dissolution and oral bioavailability: In vitro and in vivo evaluation.
  • Inugala S1, Eedara BB1, Sunkavalli S1, Dhurke R1, Kandadi P1, Jukanti R1, Bandari S2.
  • European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.Eur J Pharm Sci.2015 Jul 10;74:1-10. doi: 10.1016/j.ejps.2015.03.024. Epub 2015 Apr 3.
  • The current study was aimed to investigate the potential of solid self-nanoemulsifying drug delivery system (S-SNEDDS) composed of Capmul MCM C8 (oil), Tween 80 (surfactant) and Transcutol P (co-surfactant) in improving the dissolution and oral bioavailability of darunavir. Liquid self-nanoemulsifyi
  • PMID 25845633
  • Comparison of HIV Virologic Failure Rates Between Patients with Variable Adherence to Three Antiretroviral Regimen Types.
  • Gordon LL1, Gharibian D1, Chong K1,2, Chun H1.
  • AIDS patient care and STDs.AIDS Patient Care STDS.2015 Jul;29(7):384-8. doi: 10.1089/apc.2014.0165. Epub 2015 Jun 4.
  • Medication adherence is a major determinant of antiretroviral (ARV) treatment success and a significant challenge for HIV-positive patients, yet a well-defined adherence threshold to maintain virologic suppression on current ARV regimens remains unclear. The present study evaluated 1915 Kaiser Perma
  • PMID 26114665


  • 症例報告 DarunavirとRaltegravirを含む多剤併用療法が長期間にわたり奏効した多剤耐性HIV感染症の1例
  • 森 尚義,谷口 晴記
  • 日本エイズ学会誌 = The journal of AIDS research 15(3), 174-178, 2013
  • NAID 40019802007
  • 1PT102 HIV-1プロテアーゼによるダルナビル耐性の分子機構の解明(日本生物物理学会第50回年会(2012年度))
  • Ode Hirotaka,Suzuki Koji,Fujino Masayuki,Maejima Masami,Kimura Yuki,Masaoka Takashi,Hattori Junko,Yokomaku Yoshiyuki,Suzuki Atsuo,Watanabe Nobuhisa,Iwatani Yasumasa,Sugiura Wataru
  • 生物物理 52(SUPPLEMENT_1), S85, 2012-08-15
  • NAID 110009584941
  • Minimal effects of Darunavir on adipocyte differentiation and metabolism in 3T3-L1 cells
  • PEREZ-MATUTE Patricia,PEREZ-MARTINEZ Laura,BLANCO Jose Ramon,OTEO Jose Antonio
  • Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 18(4), 485-493, 2012-08-01
  • NAID 10030947970


If you are taking darunavir once a day and you miss a dose by less than 12 hours, take the missed dose as soon as you remember it and then take the next dose at the scheduled time. However, if you miss a dose by ...
Learn how once-daily HIV medication PREZISTA® (darunavir) 800 mg in combination with other HIV medicines can impact CD4 cell count and viral load. ... Important Safety Information What is the most important information I should ...



拡張検索darunavir ethanolate

darunavir ethanolate」

  [★] ダルナビルエタノール付加物





1マーフィー徴候 18
2narrow segment 16
3" wounds are made"  15
4グレイ症候群 15
5"phenoxypolyethoxylethanol" 15
6ロイシンエンケファリン 13
7硝酸ミコナゾール 11
8Common Laboratory Equipment 11
9content 10
10だいすいたいしんけい 9
11粟粒結核と肉下種 9
12全身性ヒマン細胞小 9
13細胞内寄生菌 9
14kligler培地 原理 9
15不整脈  9
16角膜反射 中枢 9
17膜性骨化 8
18ソルデム 8
19ハプロ不全 疾患 8
20日本多毛 8

1" wounds are made"  15
2kligler培地 原理 9
3kligler培地 硫化鉄 4
4ǸCαꥦ륹ΤǤ뤳ȤŦƤ֤Ƥ 4
5歳の女性。右目の疼痛、充血および霧視を主訴に来院した。眼底に異常を認めない。視力は右 0.9 (矯正不能)、左 1.2 (矯正不能)。眼圧は右 11 mmHg、左 12 mmHg。フルオレセイン染色後の前眼部写真 (別冊No. 5) を別に示す。 治療薬として適切なのはどれか。 4
6胃癌 borrmann分類 3
7回復過程 3
8ジェンドラシック法 メカニズム 3
9しょうすいたいしんけい 3
10ラリンゲルマスク ゼリー 3
11ハッセルバッハ三角 3
12白内障 grade 3
13フォンギールケ病 3
14マッコーネルサイン 3
15小児骨折 好発部位 3
16咽頭神経叢 3
17低アルドステロン症 3
18フロマン徴候 3
19オーグメンチン 販売中止 3
20クスマウル徴候 3